U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07244757) titled 'Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control' on Nov. 16.
Brief Summary: Ketorolac, an intravenous NSAID widely used in perioperative pain management, has been shown to reduce pain scores and opioid requirements following cesarean delivery. However, its optimal dosing regimen remains uncertain, with previous studies using doses ranging from 15 mg to 60 mg. A retrospective analysis found no significant difference between 15 mg and 30 mg doses when combined with neuraxial opioids, possibly due to overlapping multimodal analgesia components. To date, no study has directly compared the analge...